cemiplimab,fianlimab
regeneron,sanofi
['melanoma', 'melsm', 'fianlimab', 'cemiplimab']
fianlimab/cemiplimab demonstrates early clinical activity and safety in advanced melanoma #asco23 #asco2023 #melsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.